Psilocybin (Magic Mushrooms) the Most Popular Hallucinogen in the US
A new report presented by RAND shows that magic mushrooms are the most commonly used hallucinogenic substance in the US.
Discover comprehensive guides, research updates, and industry insights
A new report presented by RAND shows that magic mushrooms are the most commonly used hallucinogenic substance in the US.
Around the world, young people are increasingly using and becoming preoccupied with the internet, including social media and gaming with some developing overwhelming addictions.
A new study has investigated how the use of telehealth in opioid use disorder treatment might help reduce stigma and improve trust and autonomy.
We asked experts questions regarding accessing treatment, being able to recognize when substance abuse is a problem, who is likely to develop an addiction, and more.
This article explores how emotional support animals can help people cope with mental health conditions, including substance use disorder, and live more comfortable and enriched lives.
This blog looks at the link between weight loss drugs like Ozempic and reports of increased rates of pregnancy, even when on oral birth control.
This article examines the increased funding for psychedelic-assisted therapy from big pharma companies and the potential implications for the availability of treatment.
Mental Health Awareness Month was created in 1949 to help increase understanding and support of people with mental health issues. Find out how to get involved here.
Rebuilding a healthy relationship with food after an eating disorder can be challenging, but itΓÇÖs crucial for living life to the fullest.
We asked weight loss experts and healthcare professionals whether weight loss drugs like Ozempic hold the answers to long-term weight management, and what the potential risks are.
Tranq tourism  is a phenomenon involving social media users, particularly from platforms like YouTube and TikTok, descending on neighborhoods to film individuals using intravenous drugs.
On the third of April, 2024, US District Court Judge Gerald McHugh denied a lawsuit from the non-profit organization Safehouse, preventing the opening of a supervised drug consumption facility.